Cash Flow Statement

Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Change in Taxes Change in Taxes Change in Working Capital Change in Working Capital Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Short-Term Debt repayments

Ratios

Gain Therapeutics (GANX) Long-Term Debt Issuances (2020)

Gain Therapeutics has reported Long-Term Debt Issuances over the past 1 years, most recently at $30396.0 for Q4 2020.

Quarterly results put Long-Term Debt Issuances at $30396.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $738282.0 (changed N/A YoY), and the annual figure for FY2020 was $738282.0, changed.
Long-Term Debt Issuances for Q4 2020 was $30396.0 at Gain Therapeutics, down from $423288.0 in the prior quarter.
Over the last five years, Long-Term Debt Issuances for GANX hit a ceiling of $423288.0 in Q3 2020 and a floor of $30396.0 in Q4 2020.